Robert Jeenchen Chen

Dr. Robert Jeenchen Chen

Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California, USA
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2003 in JACC
Verified
Journal Article
Closed access
Yih-Sharng ChenYih-Sharng Chen
Yih-Sharng Chen
ACAnne Chao
Anne Chao
HYHsi-Yu Yu
Hsi-Yu Yu
WKWen-Je Ko
Wen-Je Ko
IWI-Hui Wu
I-Hui Wu
SWShoei-Shen Wang
Shoei-Shen Wang

1 July 2004 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
RHRon-Bin Hsu
Ron-Bin Hsu
Robert Jeenchen ChenRobert Jeenchen Chen
Robert Jeenchen Chen
SWShoei-Shen Wang
Shoei-Shen Wang
SCShu-Hsun Chu
Shu-Hsun Chu

1 February 2002 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
WKWen-Je Ko
Wen-Je Ko
CLChing-Yuang Lin
Ching-Yuang Lin
Robert Jeenchen ChenRobert Jeenchen Chen
Robert Jeenchen Chen
SWShoei-Shen Wang
Shoei-Shen Wang
FLFang-Yue Lin
Fang-Yue Lin
Yih-Sharng ChenYih-Sharng Chen
Yih-Sharng Chen

1 January 2005 in Gastroenterology
Verified
Journal Article
Closed access
BLBEEN-REN LIN
BEEN-REN LIN
CCCheng-Chi Chang
Cheng-Chi Chang
TCTing-Fang Che
Ting-Fang Che
SCSzu-Ta Chen
Szu-Ta Chen
Robert Jeenchen ChenRobert Jeenchen Chen
Robert Jeenchen Chen
MKMin-Liang Kuo
Min-Liang Kuo

1 November 2003 in Annals of Surgery
Verified
Journal Article
Closed access
MHMing-Te Huang
Ming-Te Huang
WLWei-Jei Lee
Wei-Jei Lee
WWWeu Wang
Weu Wang
PWPo-Li Wei
Po-Li Wei
Robert Jeenchen ChenRobert Jeenchen Chen
Robert Jeenchen Chen
Objective: To prove the feasibility of hand-assisted laparoscopic liver resection for tumors located in the posterior portion of the right hepatic lobe. Summary Background Data: Use of laparoscopic liver resection remains limited due to problems with technique, especially when the tumor is located near the diaphragm, or in the posterior portion of the right lobe. Methods: Between October 2001 and June 2002, a total of 7 patients with solid hepatic tumors involving the posterior portion of the right lobe of liver underwent hand-assisted laparoscopic hepatectomy with the HandPort system at our hospital. Surgical techniques used included CO2 pneumoperitoneum and the creation of a wound on the right upper quadrant of the abdomen for HandPort placement. The location of tumor and its transection margin were decided by laparoscopic ultrasound. The liver resection was performed using the Ultrashear without portal triad control, with the specimens obtained then placed in a bag and removed directly via the HandPort access. Results: The 5 male and 2 female patients ranged in age from 41 to 76 years (mean 62.3 ± 14.4). Surgical procedures included partial hepatectomy for 6 patients and segmentectomy for one, all successfully completed using a variant of the minimally invasive laparoscopic procedure without conversion to open surgery. The mean duration of the operation was 140.7 ± 42.2 minutes (90–180). The blood loss during surgery was 257.1 ± 159 mL (250–500), without any requirement for intraoperative or postoperative transfusion. Pathology revealed hemagioma (n = 2), colon cancer metastasis (n = 2), and hepatocellular carcinoma (n = 3). There were no deaths postoperatively, with 1 patient suffering bile leakage. Mean hospital stay was 5.3 ± 1.3 days postsurgery. Conclusion: The results of this study suggest that laparoscopic liver resection using the HandPort system is feasible for selected patients with lesions in the posterior portion of the right hepatic lobe requiring limited resection. Individuals with small tumors may benefit; because a large abdominal incision is not required, the wound-related complication rate might be reduced.

1 April 2003 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
RHRon‐Bin Hsu
Ron‐Bin Hsu
YTYeou‐Guang Tsay
Yeou‐Guang Tsay
Robert Jeenchen ChenRobert Jeenchen Chen
Robert Jeenchen Chen
SCShu‐Hsun Chu
Shu‐Hsun Chu
This study sought to find the risk factors for primary bacteremia, endovascular infection, and in-hospital death for patients without acquired immuno